Flora Peyvandi
Università degli Studi di Milano
H-index: 91
Europe-Italy
Top articles of Flora Peyvandi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy | Journal of Thrombosis and Haemostasis | Wolfgang Miesbach Barbara Konkle Pratima Chowdary Radoslaw Kaczmarek Frank Leebeek | 2024/1/18 |
Design organization and clinical processes around patient characteristics: Evidence from a multiple case study of Hemophilia | Health Services Management Research | Stefano Villa Raimondo De Cristofaro Giovanni Di Minno Simone Laratro Flora Peyvandi | 2024/2/14 |
Rare bleeding disorders: Advances in management | Haemophilia | Alessandro Casini Hanny Al‐Samkari Catherine Hayward Flora Peyvandi | 2024/3/18 |
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial | Blood | Steven W Pipe Peter Collins Christophe Dhalluin Gili Kenet Christophe Schmitt | 2024/4/4 |
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defects | Blood Transfusion | Anna Lecchi Silvia La Marca Lidia Padovan Marco Boscarino Flora Peyvandi | 2024/1 |
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis | Armando Tripodi Massimo Primignani Roberta D’Ambrosio Giulia Tosetti Vincenzo La Mura | 2024/1/12 | |
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study | Internal and Emergency Medicine | Carlotta Franchi Raffaella Rossio Sara Mandelli Ilaria Ardoino Alessandro Nobili | 2024/2/14 |
Comprehensive investigation of platelet function in patients with cirrhosis | Thrombosis Research | Anna Lecchi Giulia Tosetti Claudia Ghali Silvia La Marca Marigrazia Clerici | 2024/5/1 |
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD) | Haemophilia: the official journal of the World Federation of Hemophilia | Wolfgang Miesbach Ana Boban Pratima Chowdary Michiel Coppens Miguel Crato | 2024/3/10 |
Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia | Journal of Thrombosis and Haemostasis | Ilaria Cutica Mimosa Mortarino Isabella Garagiola Gabriella Pravettoni Flora Peyvandi | 2024/4/1 |
Ultrasound evaluation of hemophilic arthropathy: a proposal of definitions in a changing landscape | Roberta Gualtierotti Luigi Piero Solimeno Flora Peyvandi Andrea Giachi Sara Arcudi | 2024/1/3 | |
Pattern of use and clinical outcomes with rIX‐FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real‐world study | European Journal of Haematology | Paola Giordano Berardino Pollio Gianluca Sottilotta Chiara Biasoli Filomena Daniele | 2024/5 |
Emicizumab Prophylaxis for the Treatment of Infants with Severe Haemophilia A without Factor VIII Inhibitors: Primary Analysis of the HAVEN 7 Study | Hämostaseologie | J Oldenburg SW Pipe P Collins C Dhalluin G Kenet | 2024/2 |
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis (ATLAS-PPX) | Blood Journal | Gili Kenet Beatrice Nolan Osman Bülent Zülfikar Bulent Antmen Peter Kampmann | 2024/3/7 |
Clinical and laboratory presentation and underlying mechanism in patients with low VWF | Thrombosis and Haemostasis | Omid Seidizadeh Alessandro Ciavarella Luciano Baronciani Federico Boggio Francesco Ballardini | 2024/4 |
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A | Journal of Thrombosis and Haemostasis | Bella Madan Margareth C Ozelo Priyanka Raheja Emily Symington Doris V Quon | 2024/4/12 |
Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B | TH Open | Richard Lemons Michael Wang Julie Curtin Lynda Mae Lepatan Christoph Male | 2024/1 |
A simulation study to provide guidance for individuals transitioning from emicizumab to valoctocogene roxaparvovec | Hämostaseologie | S Agarwal C Hermans W Miesbach S Pipe R Sidonio | 2024/2 |
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy | Journal of Infection and Public Health | Andrea Lombardi Simone Villa Marta Colaneri Giovanni Scaglione Francesca Bai | 2024/3/1 |
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis | Blood Advances | Sara Arcudi Roberta Gualtierotti Erica Scalambrino Marigrazia Clerici Shermarke Hassan | 2024/3/28 |
